I’m excited to share that I was recently interviewed on 2GB’s “Healthy Living” program, where I discussed our team’s latest research on person-specific nanomedicine targeting leukemia. 🎧 Listen to the full interview broadcast.meltwater.com/public-api/seg…

Thank you, Will Wright, and the RMIT Media Team, for promoting our research! It is exciting to see our work featured in over 60 news outlets, including US TV news (WGN in Chicago), MSN, Yahoo News, NetEase News, AOL, and Xinhua, reaching a total audience of 86 million people.

Today is my last day RMIT University—a heartfelt thank you to my mentors, colleagues, students, and friends for your support and collaboration. Excited to start as a Lab Head ONJ Cancer Research Institute next week, advancing cancer research. Looking forward to staying connected!

I'm thrilled to share that I have received an NHMRC Investigator Grant! This fellowship will support me in developing next-generation mRNA therapeutics for cancer over the next five years. Thank you to everyone who has supported me on this journey!

Learn about the cutting-edge research from 🇦🇺🇲🇾🇿🇦 Join the Controlled Release Society Local Chapter Webinar on 21st May! Representing CRS Australia: Dr. David Ju from ONJ Cancer Research Institute Dr. Zan Dai from UNSW Moderated by Dr. Tushar Kumeria from UNSW Science 🕗 8–10 AM UTC | 6–8 PM AEST CRS Malaysia Local Chapter (MyCRS) #CRSSA

Thanks, Dr. Zan Dai and Dr. Yi (David) Ju for representing Drug Delivery Australia in the latest Controlled Release Society Local Chapter Webinar. Congrats to other speakers for your engaging talks, and thanks to everyone that joined the Webinar. We hope to see you again in future events. Stay tuned!

Thrilled to see our Comment, “Balancing stealth and targeting to improve nanomedicine efficacy”, featured in the latest Nature Nanotechnology editorial on PEGylation in nanomedicine. Our comment: doi.org/10.1038/s41565… Editorial: doi.org/10.1038/s41565…

Excited to serve as a discussion leader this afternoon at the Cancer Nanotechnology Gordon Research Seminar in Italy! Looking forward to a great session of talks and discussion. grc.org/cancer-nanotec… #GRC #nanomedicine

🚀 Our new work in Advanced Materials is out! We report a new class of polyphenol-engineered lipid nanoparticles that self-assemble into crystalline cubic & hexagonal mesophases, enabling versatile loading of drugs, proteins, polysaccharides & mRNA.advanced.onlinelibrary.wiley.com/doi/10.1002/ad…